Unknown

Dataset Information

Mutual activation of glutamatergic mGlu4 and muscarinic M4 receptors reverses schizophrenia-related changes in rodents.


ABSTRACT:

Rationale

Metabotropic glutamate receptors and muscarinic M4 receptors have been proposed as novel targets for various brain disorders, including schizophrenia. Both receptors are coupled to Go/i proteins and are expressed in brain circuits that are important in schizophrenia. Therefore, their mutual activation may be an effective treatment and allow minimizing the doses of ligands required for optimal activity.

Objectives

In the present studies, subactive doses of mGlu4 and M4 activators (LSP4-2022 and VU152100, respectively) were administered to investigate the mutual interaction between mGlu4 and M4 receptors in animal models of schizophrenia.

Methods

The behavioral tests used were MK-801-induced hyp

SUBMITTER: Cieslik P 

PROVIDER: S-EPMC6182605 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature